Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric oxygen therapy involves exposing the body to 100% oxygen at a pressure that is greater than what we normally experience. It is a non-invasive treatment with wide application in clinical medicine.

Principles:

  • 100% pure oxygen is delivered at high pressure in a closed chamber. The patient breath normally thro mouth and nose (The gas due to high pressure get compressed in body fluids (Principles of Henry’s law) at lung level.
  • O2 reaches every tissue on high concentration thereby enhancing healing capabilities of the injured tissue the healing time is reduced and pain is reduced.
  • It is similar to carbon dioxide compressed in a soda bottle.
  • It has potent anti inflammatory effect .
  • It reduces the healing time and post op recovery time.
  • It helps neovascularisation and forms new blood vessels.

INDICATION

GENERAL SURGERIES: for quick wound healing.

DIABETIC

US FDA Approved indication

  • Non healing ulcers & wounds in the foot
  • Necrotising soft tissue infection and osteomyelitis foot bone.
  • Ulcers due to varicose veins

PLASTIC SURGERIES

US FDA Approved indication

  • Acute thermal burn injury Grade I- II
  • Compromised skin grafts and flaps, enhancement of healing and selected wounds, crush injury and compartment syndrome.
OFF Label indication
  • Frost bite
  • Following abdomen plasty to reduce edema.
  • Following Flap surgeries to help wound healing

Orthopaedic

US FDA Approved indication

  • Crush injury and compartment syndrome,
  • Acute traumatic ischemia’s, Osteomyelitis,
OFF Label indication
  • Post operative reduction of edema & Wound healing, Doubtful viable flaps, Complex regional pain syndrome(Reflex sympathetic dystrophy), Fibromyalgia.

Neurology

US FDA Approved indication

  • Acute intra cranial abscess,
OFF Label indication
  • Traumatic brain injury, diffuse axonal injury.
  • Post stroke rehabilitation
  • Migraine
  • Alzemeirs

ENT

US FDA Approved indication

  • Acute sesoneurol loss (FDA).
OFF Label indication
  • Untreated tinnitus
  • Meiner's disease

Dental

US FDA Approved indication

  • Osteonecrosis on mandible (US)
  • Osteomyelitis of mandible

Oncology

US FDA Approved indication

  • Delayed radiation injury, Soft tissue and necrosis

UROLOGY

  • Pyelonephritis
  • Hemorrhagic cystitis

Miscellaneous

US FDA Approved indication

  • Carbon monoxide poisoning, Gas gangrene

Results

  • LEFT LEG CELLULITES

    Results : Left leg cellulites 1 st day

    Left leg cellulites1

    Results : Left leg cellulites 15th day

    Left leg cellulites15

  • BONE INFECTION

    CONDITION NAME: BONE INFECTION 1 ST DAY

    BONE INFECTION1

    CONDITION NAME: BONE INFECTION 10th DAY 

    BONE INFECTION 10

    CONDITION NAME: BONE INFECTION 15th DAY

    BONE INFECTION 20

  • OSTEOMYELITIS

    CONDITION: OSTEOMYELITIS 1ST DAY

    OSTEOMYELITIS 1

    CONDITION: OSTEOMYELITIS 13th SAY

    OSTEOMYELITIS 13

    CONDITION: OSTEOMYELITIS 28th DAY

    OSTEOMYELITIS 28

    CONDITION: OSTEOMYELITIS 35th DAY

    OSTEOMYELITIS 35

  • CRUSH INJURY

    CONDITION: CRUSH INJURY 1st DAY

    CRUSH INJURY 1

    CONDITION: CRUSH INJURY 5th DAY

    CRUSH INJURY 5

    CONDITION: CRUSH INJURY 10th DAY

    CRUSH INJURY 10

    CONDITION: CRUSH INJURY 10th DAY

    CRUSH INJURY 10 2